| RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition S Koszegi, A Molnar, L Lenart, J Hodrea, DB Balogh, T Lakat, ... The Journal of physiology 597 (1), 193-209, 2019 | 81 | 2019 |
| σ1-receptor agonism protects against renal ischemia-reperfusion injury A Hosszu, Z Antal, L Lenart, J Hodrea, S Koszegi, DB Balogh, NF Banki, ... Journal of the American Society of Nephrology 28 (1), 152-165, 2017 | 56 | 2017 |
| Role of O-linked N-acetylglucosamine modification in diabetic nephropathy R Gellai, J Hodrea, L Lenart, A Hosszu, S Koszegi, D Balogh, A Ver, ... American Journal of Physiology-Renal Physiology 311 (6), F1172-F1181, 2016 | 44 | 2016 |
| Reduced O-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney J Hodrea, DB Balogh, A Hosszu, L Lenart, B Besztercei, S Koszegi, ... American Journal of Physiology-Renal Physiology 318 (4), F1017-F1029, 2020 | 36 | 2020 |
| The role of sigma-1 receptor and brain-derived neurotrophic factor in the development of diabetes and comorbid depression in streptozotocin-induced diabetic rats L Lenart, J Hodrea, A Hosszu, S Koszegi, D Zelena, D Balogh, ... Psychopharmacology 233, 1269-1278, 2016 | 27 | 2016 |
| SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes J Hodrea, A Saeed, A Molnar, A Fintha, A Barczi, LJ Wagner, AJ Szabo, ... PLoS One 17 (2), e0263285, 2022 | 22 | 2022 |
| Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling L Lenart, DB Balogh, N Lenart, A Barczi, A Hosszu, T Farkas, J Hodrea, ... Diabetologia 62, 1501-1513, 2019 | 22 | 2019 |
| The role of Sigma‐1 receptor in sex‐specific heat shock response in an experimental rat model of renal ischaemia/reperfusion injury A Hosszu, Z Antal, A Veres‐Szekely, L Lenart, DB Balogh, E Szkibinszkij, ... Transplant International 31 (11), 1268-1278, 2018 | 20 | 2018 |
| Antidepressant effect in diabetes-associated depression: A novel potential of RAAS inhibition DB Balogh, A Molnar, A Hosszu, T Lakat, J Hodrea, AJ Szabo, L Lenart, ... Psychoneuroendocrinology 118, 104705, 2020 | 15 | 2020 |
| An overview of the cardioprotective effects of novel antidiabetic classes: focus on inflammation, oxidative stress, and fibrosis DB Balogh, LJ Wagner, A Fekete International Journal of Molecular Sciences 24 (9), 7789, 2023 | 7 | 2023 |
| FP429 THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS AMELIORATE HYPERGLYCAEMIA INDUCED TUBULOINTERSITIAL FIBROSIS IN DIABETIC NEPHROPATHY A Molnar, S Koszegi, L Lenart, J Hodrea, D Balogh, E Szkibinszkij, ... Nephrology Dialysis Transplantation 33 (suppl_1), i179-i179, 2018 | 2 | 2018 |
| Cardioprotective and Antifibrotic Effects of Low-Dose Renin–Angiotensin–Aldosterone System Inhibitors in Type 1 Diabetic Rat Model DB Balogh, A Molnar, A Degi, A Toth, L Lenart, A Saeed, A Barczi, ... International Journal of Molecular Sciences 24 (23), 17043, 2023 | 1 | 2023 |
| 10-LB: Activation of Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease DB BALOGH, L LENART, A HOSSZU, A SAEED, J HODREA, AR TOTH, ... Diabetes 72 (Supplement_1), 2023 | 1 | 2023 |
| MO620 antifibrotic effects of SGLT2 inhibition in the kidney and proximal tubular cells D Balogh, J Hodrea, A Hosszu, T Lakat, A Saeed, L Lenart, L Wagner, ... Nephrology Dialysis Transplantation 36 (Supplement_1), gfab093. 001, 2021 | 1 | 2021 |
| A nátrium-glükóz-kotranszporterek szerepe a diabeteses nephropathiában J Hodrea, DB Balogh, L Lénárt, S Kőszegi, Á Hosszú, Á Vannay, ... | 1 | 2015 |
| Sigma-1 receptor agonist mitigates bleomycin-induced pulmonary fibrosis in mice A Hosszu, DB Balogh, AR Toth, J Hodrea, Z Helyes, AJ Szabo, A Fekete European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| A vese védelmében és azon is túl: A renoprotekció új lehetőségei= For kidney protection and beyond: New possibilities of renoprotection DB Balogh, A Fekete, G Reusz HYPERTONIA ÉS NEPHROLOGIA 27 (2), 83-89, 2023 | | 2023 |
| SIGMA-1 RECEPTOR AGONISTS ARE PROTECTIVE IN RENAL ISCHEMIA/REPERFUSION INJURY AR Toth, T Lakat, J Hodrea, DB Balogh, A Vannay, L Wagner, A Szabo, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 37, I201-I201, 2022 | | 2022 |
| MO282: Sigma-1 Receptor Agonists are Protective in Renal Ischemia/Reperfusion Injury A Roland Toth, T Lakat, J Hodrea, DB Balogh, A Vannay, L Wagner, ... Nephrology Dialysis Transplantation 37 (Supplement_3), gfac067. 081, 2022 | | 2022 |
| A Novel Potential of SGLT2 Inhibition: Antifibrotic Effect in Diabetes DB Balogh, J Hodrea, A Hosszu, L Lenart, T Lakat, A Saeed, ... The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
